Clovis Oncology's GAAP loss for 9M 2021 was $200.133 million, down 25.9% from $270.254 million in the prior year. Revenue decreased 7% to $112.789 million from $121.223 million a year earlier.
Clovis Oncology's GAAP loss for 9M 2021 was $200.133 million, down 25.9% from $270.254 million in the prior year. Revenue decreased 7% to $112.789 million from $121.223 million a year earlier. 
ir.clovisoncology.com
English (US) 